Kosan Reprioritizes Pipeline As CEO Johnson Exits
This article was originally published in The Pink Sheet Daily
Executive Summary
Senior VP and Chief Business Officer Kim is appointed president, but the biotech has no plans to appoint a new CEO.
You may also be interested in...
Kosan Plans 37% Workforce Cut; Kim Rises To CEO
California biotech places most early research on hold to advance lead clinical candidates.
Kosan Plans 37% Workforce Cut; Kim Rises To CEO
California biotech places most early research on hold to advance lead clinical candidates.
Roche Backs Out Of Kosan Epothilone Deal
Kosan is “actively seeking” a new partner to begin Phase II trial for KOS-1584 after Roche unexpectedly terminates five-year collaboration.